Study highlights challenges of shared decision-making in advanced lung cancer care

A new study shows that patients can experience reduced co-determination and insufficient information about their cancer treatment, while doctors face pressure to give treatment they do not consider useful.

AstraZeneca’s rare blood disorder pill approved in Japan

AstraZeneca’s add-on pill for the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) won its first approval in Japan, the company announced Friday. The drug, an

January 20, 2024

How climate change is driving a global epidemic of immune health problems, and how to stop it

Many of the effects of climate change play out at a very large scale: Heatwaves that grip entire continents. Flooding that submerges vast swaths of

April 4, 2024

APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program – Biotech Investments

APONTIS PHARMA AG / Key word(s): Strategic Company Decision/Restructure of Company APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program 08-Nov-2023

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.